The prevention of TLR-9 signalling may be one mechanism by which anti-malarial drugs, such as chloroquine and hydroxychloroquine, could possibly exert their beneficial effects in women with preeclampsia or aPL66,67. This evidence concerns the gene TLR9 and preeclampsia.